Directory
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Degree: PhD

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publications

  • Castelblanco, E; Zafon, C; Maravall, J; Gallel, P; Martinez, M; Capel, I; Bella, MR; Halperin, I; Temprana, J; Iglesias, C; Puig-Domingo, M; Robledo, M; Matias-Guiu, X; Mauricio, D

    APLP2, RRM2, and PRC1: New Putative Markers for the Differential Diagnosis of Thyroid Follicular Lesions

    Thyroid 27 59-66. .

    [doi:10.1089/thy.2016.0094]

  • Eritja, N; Yeramian, A; Chen, BJ; Llobet-Navas, D; Ortega, E; Colas, E; Abal, M; Dolcet, X; Reventos, J; Matias-Guiu, X

    Endometrial Carcinoma: Specific Targeted Pathways

    Advances in Experimental Medicine and Biology 943 149-207. .

    [doi:10.1007/978-3-319-43139-0_6]

  • Mota, A; Colas, E; Garcia-Sanz, P; Campoy, I; Rojo-Sebastian, A; Gatius, S; Garcia, A; Chiva, L; Alonso, S; Gil-Moreno, A; Gonzalez-Tallada, X; Diaz-Feijoo, B; Vidal, A; Ziober-Malinowska, P; Bobinski, M; Lopez-Lopez, R; Abal, M; Reventos, J; Matias-Guiu, X; Moreno-Bueno, G

    Genetic analysis of uterine aspirates improves the diagnostic value and captures the intra-tumor heterogeneity of endometrial cancers

    Modern Pathology 30 134-145. .

    [doi:10.1038/modpathol.2016.143]

  • Piulats, JM; Matias-Guiu, X

    Immunotherapy in Endometrial Cancer: In the Nick of Time

    CLINICAL CANCER RESEARCH 22 5623-5625. .

    [doi:10.1158/1078-0432.CCR-16-1820]

  • Lecube, A; Valladares, S; Lopez-Cano, C; Gutierrez, L; Ciudin, A; Fort, JM; Reñé JM; Matias-Guiu, X; de Torres, I; Bueno, M; Pallares, J; Baena, JA

    The Role of Morbid Obesity in the Promotion of Metabolic Disruptions and Non-Alcoholic Steatohepatitis by Helicobacter Pylori

    PLOS ONE 11 -. .

    [doi:10.1371/journal.pone.0166741]

  • Rosa-Rosa, JM; Leskela, S; Cristobal-Lana, E; Santon, A; Lopez-Garcia, MA; Muñoz G; Perez-Mies, B; Biscuola, M; Prat, J; Esther, OE; Soslow, RA; Matias-Guiu, X; Palacios, J

    Molecular genetic heterogeneity in undifferentiated endometrial carcinomas

    Modern Pathology 29 1390-1398. .

    [doi:10.1038/modpathol.2016.132]

  • Jonsson, M; Ragnum, HB; Julin, CH; Yeramian, A; Clancy, T; Frikstad, KAM; Seierstad, T; Stokke, T; Matias-Guiu, X; Ree, AH; Flatmark, K; Lyng, H

    Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibition

    BRITISH JOURNAL OF CANCER 115 929-939. .

    [doi:10.1038/bjc.2016.278]

  • Moran, S; Martinez-Cardus, A; Sayols, S; Musulen, E; Balañá C; Estival-Gonzalez, A; Moutinho, C; Heyn, H; Diaz-Lagares, A; de Moura, MC; Stella, GM; Comoglio, PM; Ruiz-Miro, M; Matias-Guiu, X; Pazo-Cid, R; Anton, A; Lopez-Lopez, R; Soler, G; Longo, F; Guerra, I; Fernandez, S; Assenov, Y; Plass, C; Morales, R; Carles, J; Bowtell, D; Mileshkin, L; Sia, D; Tothill, R; Tabernero, J; Llovet, JM; Esteller, M

    Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis

    LANCET ONCOLOGY 17 1386-1395. .

    [doi:10.1016/S1470-2045(16)30297-2]

  • Aldecoa, I; Atares, B; Tarragona, J; Bernet, L; Sardon, JD; Pereda, T; Villar, C; Mendez, MC; Gonzalez-Obeso, E; Elorriaga, K; Alonso, GL; Zamora, J; Planell, N; Palacios, J; Castells, A; Matias-Guiu, X; Cuatrecasas, M

    Molecularly determined total tumour load in lymph nodes of stage I-II colon cancer patients correlates with high-risk factors. A multicentre prospective study

    VIRCHOWS ARCHIV 469 385-394. .

    [doi:10.1007/s00428-016-1990-1]

  • van der Putten, LJM; Visser, NCM; van de Vijver, K; Santacana, M; Bronsert, P; Bulten, J; Hirschfeld, M; Colas, E; Gil-Moreno, A; Garcia, A; Mancebo, G; Alameda, F; Trovik, J; Kopperud, RK; Huvila, J; Schrauwen, S; Koskas, M; Walker, F; Weinberger, V; Minar, L; Jandakova, E; Snijders, MPLM; van den Berg-van Erp, S; Matias-Guiu, X; Salvesen, HB; Amant, F; Massuger, LFAG; Pijnenborg, JMA

    L1CAM expression in endometrial carcinomas: an ENITEC collaboration study

    BRITISH JOURNAL OF CANCER 115 716-724. .

    [doi:10.1038/bjc.2016.235]

  • Guerra, E; Vidal, A; Gatius, S; Velasco, A; Piulats, JM; Ponce, J; Tallada, XG; Pardo, B; Martin, MG; Ortega, E; Guiu, XM

    Molecular classification of grade 3 endometrioid endometrial carcinomas: A retrospective study

    VIRCHOWS ARCHIV 469 20-20. .

  • Martinez-Garcia, E; Lesur, A; Devis, L; Campos, AR; Cabrera, S; van Oostrum, J; Matias-Guiu, X; Gil-Moreno, A; Reventos, J; Colas, E; Domon, B

    Development of a sequential workflow based on LC-PRM for the verification of endometrial cancer protein biomarkers in uterine aspirate samples

    Oncotarget 7 53102-53115. .

    [doi:10.18632/oncotarget.10632]

Projects

  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
  • Genomic approach for individualizing endometrial cancer diagnosis, prognosis and treatment